Glycaemic Index (GI) Evaluation of Carbohydrate-based Food With Functional

Status Completed

Clinical Trial Summary

In Singapore, the Ministry of Health has declared a "War on Diabetes" and major efforts will be made to develop and deploy programs to prevent diabetes. One of the cornerstones of diabetes management involves dietary modifications to reduce postprandial hyperglycaemia. However, implementation of a low GI diet is highly complex requiring the individual to choose foods from a long list which are primarily based on western consumption patterns. Many foods in the Asian diet, which largely consist of carbohydrates such as white rice, noodles and other flour based products, are not represented. An alternative solution will require innovative ways to alter commonly available food products that will not only help reduce postprandial glycaemia but also preserve the sensory characteristics of the foods to create a new generation of food products both functional and palatable. One such approach is the incorporation of plant compounds that lower the glucose absorption from foods. The aim of the project is to measure the GI of carbohydrate-based food with edible plant derived molecules. Natural, plant-derived anthocyanin will be incorporated into bread to produce low GI bread. Anthocyanins are well known for its anti-oxidant activity and recent studies reported that anthocyanins also had an inhibitory activity against digestive enzymes that break down carbohydrates. It can potentially inhibit amylase, and suppress the increase in postprandial glucose level from starch. Bread is a carbohydrate-rich product, which contains a high amount of rapidly digestible starch, and therefore many of them have a high GI. This study aims to determine the glycaemic effects of anthocyanin fortified bread. The effort is designed to enable and inform population interventions that will have an impact on the health of the population in a sustainable manner by introducing innovative foods into the food supply that are 'health promoting' based on rigorous human experiments and are acceptable to the public and other major stakeholders.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03989674
Study type	Interventional
Source	National University, Singapore
Contact
Status	Completed
Phase	N/A
Start date	October 27, 2017
Completion date	December 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03932695` - Investigation of Milk Peptides on Postprandial Blood Glucose Profile	N/A
Completed	`NCT03159065` - Postprandial Efficacy of Probiotic Fruit Beverages on Glucose Tolerance and Insulin Resistance	N/A
Completed	`NCT04499287` - Mealtime Walking Study to Improve Postprandial Metabolic Response	N/A
Completed	`NCT04063137` - Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals	N/A
Active, not recruiting	`NCT05460884` - Effects of Seaweed Extract on Postprandial Response to White Bread	N/A
Completed	`NCT05405010` - Individually Timed Stair Climbing and Descending to Lower Postprandial Glucose	N/A
Completed	`NCT05161182` - Westlake N-of-1 Trials for Macronutrient Intake 2 ( WE-MACNUTR 2)	N/A
Completed	`NCT04125602` - Westlake N-of-1 Trials for Macronutrient Intake	N/A
Completed	`NCT02896010` - Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes	N/A
Completed	`NCT04476693` - Metabolic Responses to Breakfast in Adolescent Girls	N/A
Completed	`NCT05231642` - Individualised Postprandial Glucose Responses in Type 1 Diabetes	N/A
Completed	`NCT03374501` - Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™	N/A
Completed	`NCT05000944` - Is Mid-morning Breakfast as Healthy as Early-morning Breakfast for Blood Sugar Control in Adolescent Girls?	N/A
Recruiting	`NCT04243629` - Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes	N/A
Completed	`NCT04289545` - Postprandial Effects of Functional Bread	N/A
Completed	`NCT04018976` - AVACEN Treatment Method and Postprandial Blood Glucose	N/A
Completed	`NCT00771693` - Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)	Phase 4
Completed	`NCT00930956` - Comparison of Different Types of Resistant Starch	N/A
Recruiting	`NCT04419948` - Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM	N/A
Completed	`NCT04430439` - Emotion-Diet Interactions in Pregnancy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Glycaemic Index (GI) Evaluation of Carbohydrate-based Food With Functional Ingredients Derived From Food Sources

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms